A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies

• Peter J. Hotez ,

  * E-mail: hotez@bcm.edu (PJH); younbeen.kim@rightfund.org (YK)

  Affiliations RIGHT Fund, Seoul, Republic of Korea, Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America

  http://orcid.org/0000-0001-8770-1042

  ⨯
• Kim Bush,

  Affiliations RIGHT Fund, Seoul, Republic of Korea, Life Sciences Partnerships, Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Andrin Oswald,

  Affiliations RIGHT Fund, Seoul, Republic of Korea, Life Sciences Partnerships, Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Glenn Rockman,

  Affiliations RIGHT Fund, Seoul, Republic of Korea, Adjuvant Capital, New York, New York, United States of America

  http://orcid.org/0000-0003-4260-9378

  ⨯
• In-taek Lim,

  Affiliations RIGHT Fund, Seoul, Republic of Korea, Korean Ministry of Health and Welfare (MOHW), Sejong, Republic of Korea

  ⨯
• Youngmee Jee,

  Affiliations RIGHT Fund, Seoul, Republic of Korea, Center for Infectious Disease Research at the National Institute of Health, Korea Centers for Disease Control & Prevention (CDC), Osong, Republic of Korea

  ⨯
• Chang Jin Moon,

  Affiliation RIGHT Fund, Seoul, Republic of Korea

  ⨯
• Jerome H. Kim,

  Affiliation International Vaccine Institute (IVI), Seoul, Republic of Korea

  ⨯
• Younbeen Kim

  * E-mail: hotez@bcm.edu (PJH); younbeen.kim@rightfund.org (YK)

  Affiliation RIGHT Fund, Seoul, Republic of Korea

  ⨯